Drug Pipeline

SHR-A1921 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06649331 Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer Advanced Breast Cancer Recruiting
NCT05582499 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study… Breast Neoplasm Recruiting
NCT05924256 A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing Advanced Salivary Gland Carcinoma Active, Not Recruiting
Sponsors Running SHR-A1921 Trials
Fudan University (3)
Disease Areas
Breast Cancer (2) Triple-Negative Breast Cancer (2) HER2-Positive Breast Cancer (1)
Get alerts when SHR-A1921 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free